Ultrasound Denervation Product
Employees: 11-50
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
Mentions in press and media 15
| Date | Title | Description | Source |
| 24.08.2023 | ReCor Medical wins FDA panel nod for its renal denervation... | This ReCor Medical illustration shows the Paradise renal denervation catheter during the procedure. ... | massdevice... |
| 19.09.2022 | ReCor Medical ultrasound renal denervation trial meets prima... | This ReCor Medical illustration shows the Paradise renal denervation catheter during the procedure. ... | massdevice... |
| 17.05.2021 | ReCor Medical Announces Results from Landmark RADIANCE-HTN T... | PALO ALTO, Calif., May 17, 2021 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-ow... | en.prnasia... |
| 11.07.2018 | Term Sheet — Wednesday, July 11 | 5 Qs WITH A DEALMAKER Even though Polina is out, she prepared this Q&A below for Term Sheet. Pl... | fortune.co... |
| 10.07.2018 | Sofinnova Partners Sells ReCor Medical to Otsuka Holdings | Sofinnova Partners, a Paris, France-based venture capital firm specialized in Life Sciences, announc... | finsmes.co... |
| 07.04.2016 | ReCor Medical enrolls first patients for study to test devic... | The company raised a $15 million Series D round in April 2015, and it won an investigation device ex... | medcitynew... |
| 13.04.2015 | ReCor Medical raises $15M for ultrasound RDN | A Japanese healthcare conglomerate is the lead investor ReCor Medical‘s $15 million Series D round R... | massdevice... |
| 23.10.2014 | Stealth hypertension startup Sympara Medical raises nearly $... | Stealthy Sympara Medical quietly secured $5.5 million in funding from a handful of investors for the... | massdevice... |
| 28.02.2014 | Still in the renal denervation space? Startups, consider ada... | For instance, if a sub-population of patients seems to respond with much more efficacious outcomes t... | medcitynew... |
| 30.05.2012 | Renal denervation by ultrasound may set apart Kona in hypert... | An estimated 10 percent to 20 percent of the 78 million U.S. patients with hypertension don’t respon... | medcitynew... |
Show more